Safety of HIV medications – new podcast out now

In focus / 04 May 2022

Henry Zakumumpa from Makerere University School of Public Health airs his research on HIV care and treatment strategies in Uganda and the need for more robust pharmacovigilance.


With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects.  

In the latest episode of Drug Safety Matters, Henry Zakumumpa from Makerere University School of Public Health tells podcast host Federica Santoro about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda. 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

Strengthening healthcare systems against substandard medicines

Rethinking Medical Device Safety in a Drug-Centric World

How diclofenac drove vultures to the brink and unleashed a rabies crisis

You may also like

Strengthening healthcare systems against substandard medicines

Counterfeit drugs threaten millions worldwide, yet healthcare workers often lack training to spot fakes or report them, leaving this problem largely invisible.

01 October 2025

How diclofenac drove vultures to the brink and unleashed a rabies crisis

How one unusual crisis highlights the need to more effectively integrate the One Health approach and ecopharmacovigilance into pharmaceutical monitoring and legislation.

20 August 2025

Rethinking Medical Device Safety in a Drug-Centric World

From software updates to complex human-machine interactions, medical devices pose safety challenges that require dedicated frameworks beyond drug vigilance.

28 August 2025